pharmaceutical industryScienceThe US Finally Approved an Over-the-Counter Birth Control Pill. Here’s What to KnowBy Emily MullinScienceA One-Time Shot for Type 2 Diabetes? A Biotech Company Is On ItBy Emily MullinScienceAbortion Pill Use Is Surging. Now It’s Under ThreatBy Emily Mullin and Kate KnibbsScienceA Pill Version of Ozempic Is ComingBy Emily MullinScienceA Critical New Drug Is Coming—Unless Agriculture Gets There FirstBy Maryn McKennaScienceThe US Supreme Court Restores Access to Abortion Pills—for NowBy Emily MullinScienceA Crucial Group of Covid Drugs Has Stopped WorkingBy Emily MullinScienceThe Antibiotic Resistance Crisis Has a Troubling TwistBy Maryn McKennaScienceDrug Shortages Aren’t New. The Tripledemic Just Made You LookBy Maryn McKennaScienceThe Era of One-Shot, Multimillion-Dollar Genetic Cures Is HereBy Emily MullinCultureAmerica’s Adderall Shortage Could Kill PeopleBy Kate KnibbsScienceBig Pharma Says Drug Prices Reflect R&D Cost. Researchers Call BSBy Grace BrowneScienceHow Does a Variant-Specific Covid Booster Work?By Emily MullinBusinessMartin Shkreli Is Back With a Web3 Drug Discovery PlatformBy Beth Mole, Ars TechnicaScienceCalifornia Wants to Make Cheap Insulin. Here’s How It Could WorkBy Emily MullinScienceThe Covid Virus Keeps Evolving. Why Haven't Vaccines?By Emily MullinScienceThe First Drug-Releasing Contact Lens Is HereBy Emily MullinScienceBig Pharma's Ethical Dilemma: Should They Keep Selling to Russia?By Grace BrowneScienceNew Covid Drugs Are Here—and They Could Change the PandemicBy Adam RogersScienceA Vaccine Against Valley Fever Finally Works—for DogsBy Maryn McKennaScienceThe Malaria Vaccine Is a Big Deal, but Not a Silver BulletBy Sara HarrisonThe Big StoryBlood, Lies, and a Drug Trials Lab Gone BadBy Brendan I. KoernerScienceBetter Data on Ivermectin Is Finally on Its WayBy Adam RogersScienceThe US Is Getting Covid Booster Shots. The World Is FuriousBy Maryn McKennaMore Stories
.jpg)
